BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2720597)

  • 1. External beam radiotherapy for carcinoma of the prostate.
    Sagerman RH; Chun HC; King GA; Chung CT; Dalal PS
    Cancer; 1989 Jun; 63(12):2468-74. PubMed ID: 2720597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
    Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
    Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenocarcinoma of the prostate treated with external-beam radiation therapy: 5-year minimum follow-up.
    Amdur RJ; Parsons JT; Fitzgerald LT; Million RR
    Radiother Oncol; 1990 Jul; 18(3):235-46. PubMed ID: 2120741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photon neutron mixed-beam radiotherapy of locally advanced prostate cancer.
    Haraf DJ; Rubin SJ; Sweeney P; Kuchnir FT; Sutton HG; Chodak GW; Weichselbaum RR
    Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):3-14. PubMed ID: 7642429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technical and tumor-related factors affecting outcome of definitive irradiation for localized carcinoma of the prostate.
    Perez CA; Lee HK; Georgiou A; Logsdon MD; Lai PP; Lockett MA
    Int J Radiat Oncol Biol Phys; 1993 Jul; 26(4):581-91. PubMed ID: 8330986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone.
    Shipley WU; Verhey LJ; Munzenrider JE; Suit HD; Urie MM; McManus PL; Young RH; Shipley JW; Zietman AL; Biggs PJ
    Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):3-12. PubMed ID: 7721636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformal high dose rate iridium-192 boost brachytherapy in locally advanced prostate cancer: superior prostate-specific antigen response compared with external beam treatment.
    Stromberg JS; Martinez AA; Horwitz EM; Gustafson GS; Gonzalez JA; Spencer WF; Brabbins DS; Dmuchowski CF; Hollander JB; Vicini FA
    Cancer J Sci Am; 1997; 3(6):346-52. PubMed ID: 9403047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iodine-125 implants versus external beam therapy for stages A2, B, and C prostate cancer.
    Morton JD; Peschel RE
    Int J Radiat Oncol Biol Phys; 1988 Jun; 14(6):1153-7. PubMed ID: 3133328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above.
    Kupelian PA; Buchsbaum JC; Elshaikh M; Reddy CA; Zippe C; Klein EA
    Cancer; 2002 Dec; 95(11):2302-7. PubMed ID: 12436435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer: results of external irradiation.
    Reddy EK; Krishnan L; Giri S; Evans RG; Mebust WK; Weigel JW
    J Natl Med Assoc; 1993 Feb; 85(2):109-12. PubMed ID: 8441185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of whole pelvis versus small-field radiation therapy for carcinoma of prostate.
    Ploysongsang S; Aron BS; Shehata WM; Jazy FK; Scott RM; Ho PY; Morand TM
    Urology; 1986 Jan; 27(1):10-6. PubMed ID: 3079933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic body re-irradiation therapy for locally recurrent prostate cancer after external-beam radiation therapy: Initial report.
    Janoray G; Reynaud-Bougnoux A; Ruffier-Loubière A; Bernadou G; Pointreau Y; Calais G
    Cancer Radiother; 2016 Jun; 20(4):275-81. PubMed ID: 27342944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing outcome of definitive radiotherapy for localized carcinoma of the prostate.
    Perez CA; Garcia D; Simpson JR; Zivnuska F; Lockett MA
    Radiother Oncol; 1989 Sep; 16(1):1-21. PubMed ID: 2554371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External beam radiotherapy in cancer of the prostate. The University of Arizona experience.
    Aristizabal SA; Steinbronn D; Heusinkveld RS
    Radiother Oncol; 1984 Mar; 1(4):309-15. PubMed ID: 6505267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative radiotherapy for stage pT3 carcinoma of the prostate: improved local control.
    Syndikus I; Pickles T; Kostashuk E; Sullivan LD
    J Urol; 1996 Jun; 155(6):1983-6. PubMed ID: 8618303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is long-term survival possible with external beam irradiation for stage D1 adenocarcinoma of the prostate?
    Lawton CA; Cox JD; Glisch C; Murray KJ; Byhardt RW; Wilson JF
    Cancer; 1992 Jun; 69(11):2761-6. PubMed ID: 1571906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypofractionated external beam radiotherapy to boost the prostate with ≥85 Gy/equivalent dose for patients with localised disease at high risk of lymph node involvement: feasibility, tolerance and outcome.
    Zilli T; Jorcano S; Escudé L; Linero D; Rouzaud M; Dubouloz A; Miralbell R
    Clin Oncol (R Coll Radiol); 2014 Jun; 26(6):316-22. PubMed ID: 24667210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy for localized prostate carcinoma.
    Rosen EM; Cassady JR; Connolly J; Chaffey JT
    Int J Radiat Oncol Biol Phys; 1984 Dec; 10(12):2201-10. PubMed ID: 6439698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose-rate iridium-192 afterloading therapy combined with external beam radiotherapy for T1c-T3bN0M0 prostate cancer.
    Jo Y; Hiratsuka J; Fujii T; Takenaka A; Fujisawa M
    Urology; 2004 Sep; 64(3):556-60. PubMed ID: 15351592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.